儿科马芬综合征和心脏移植:来自PHIS数据库的见解
Stephanie S Philip1,2, Hugo R Martinez1,2, Matthew F Mikulski3
1Texas Center for Pediatric and Congenital Heart Disease, Dell Medical School at the University of Texas at Austin, Austin, Texas, USA.
Pediatric transplantation
|November 17, 2025
概括
接受心脏移植的儿科马凡综合征 (MFS) 患者在短期内显示出有希望的结果. 这项研究没有发现与MFS相关的显著外科并发症,这挑战了这些心力衰竭患者的当前做法.
科学领域:
- 心脏病学 心脏病学
- 儿科手术 儿科手术
- 遗传学 是一个遗传学.
背景情况:
- 马凡综合征 (MFS) 是一种遗传性结合组织疾病.
- 长期无休症经常导致严重的心血管并发症,包括心力衰竭.
- 儿科MFS患者的正管心脏移植 (OHT) 由于潜在的大动脉并发症而引起争议.
研究的目的:
- 评估接受心脏移植 (OHT) 的儿科马凡综合征患者的结果.
- 为了比较OHT在MFS患者中的安全性和有效性与非MFS接受者.
- 评估MFS对移植后并发症和存活率的影响.
主要方法:
- 对儿科健康信息系统 (PHIS) 数据库 (2004-2024) 的回顾性审查.
- 识别经过OHT的MFS的儿科患者 (<18岁).
- 倾向性得分匹配 (3:1) 的MFS患者与非MFSOHT接受者.
- 对结果的分析,包括移植失败,大动脉事件和没有再移植的生存率.
主要成果:
- 在5493名OHT接受者中,确定了10名儿科MFS患者.
- 随访时间中位数为3.73年;没有发生住院死亡或再移植.
- 两名MFS患者经历了排斥;一个患者在没有干预的情况下发生了大动脉根扩张.
- 倾向匹配分析显示,MFS和非MFS队列之间的排斥,大动脉事件或存活率没有显著差异.
结论:
- 儿科马凡综合征患者在OHT后表现出很好的短期结果.
- 在这个队列中没有观察到与MFS相关的外科并发症.
- 结果表明OHT可能是选择儿科MFS患者的可行选择,需要进一步的长期研究.
相关概念视频
01:22Mitral Stenosis I: Introduction
423
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
423
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
380
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
380
01:26Mitral Stenosis III: Medical Management
229
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
229